“Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Whose Disease Did Not Respond to Prior Biologics” (2019) SKIN The Journal of Cutaneous Medicine, 3, p. S22. doi:10.25251/skin.3.supp.22.